VREX — Varex Imaging Corporation

Varex Imaging Q2 Fiscal Year 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $216 million, up 1% year-over-year, within guidance.
• Non-GAAP Gross Margin: 34%, at the high end of expectations but down 240 basis points from the previous year.
• Non-GAAP EPS: $0.21, consistent with expectations.
• Operating Income: $19 million, down from $26 million year-over-year; operating margin at 9%.
• GAAP Loss: Net loss of $8 million, GAAP EPS loss of $0.19.
• Cash Position: Cash, cash equivalents, and marketable securities totaled $88 million, down $37 million from the previous quarter.
• Debt: Gross debt of $351 million; net debt of $263 million after cash adjustments.

2. Strategic Updates and Business Highlights

• Medical Segment: Revenue of $156 million, driven by strong CT sales. New product investments are increasing OEM project discussions.
• Industrial Segment: Revenue of $60 million, with growth in cargo security systems and photon counting technology.
• Product Development: Continued focus on advanced imaging technologies, including AI integration in imaging systems.
• Market Engagement: Strong customer engagement in both medical and industrial sectors, with a focus on innovation and new applications.
• Debt Refinancing: Successfully completed refinancing, reducing annual interest expense and improving financial flexibility.

3. Forward Guidance and Outlook

• Annual Revenue Guidance: Expected to be between $860 million and $880 million for fiscal year 2026, reflecting a 3% increase in the second half compared to the same period in fiscal 2025.
• Q3 Guidance: Revenue expected between $210 million and $225 million; non-GAAP EPS anticipated between $0.15 and $0.30.
• Long-term Outlook: Continued growth anticipated in both segments, particularly in industrial applications and photon counting technology.

4. Bad News, Challenges, or Points of Concern

• Gross Margin Pressure: Decline attributed to higher costs, particularly in memory chips and other input materials.
• Operating Expenses: Increased to $54 million, higher than expected, primarily due to investments in growth initiatives.
• Regional Performance: EMEA revenue declined by 16%, attributed to a large customer order in the previous year that did not repeat.
• Inventory Levels: Increased by $19 million, with expectations to reduce inventory by $20 million to $25 million in the next six months.

5. Notable Q&A Insights

• Macro Environment Impact: Management noted minimal direct impact from geopolitical tensions on logistics; however, there are concerns about rising costs and availability of certain components.
• India Manufacturing Ramp: Current capacity utilization is low, with expectations to increase significantly by year-end as regulatory approvals are obtained.
• Photon Counting Technology: Strong interest from multiple OEMs, with two customers actively developing CT systems using this technology.
• Pricing Power: Management indicated the ability to pass on increased costs to customers, although current conditions have not necessitated significant price adjustments.
• Annual Guidance Resumption: Management expressed confidence in providing annual guidance again due to improved forecasting and stability in demand.

This summary encapsulates the key points from Varex Imaging's Q2 2026 earnings call, highlighting financial performance, strategic initiatives, future outlook, and challenges faced by the company.